Source: American Journal of Infectious Diseases. Unidades: FORP, FMRP
Subjects: SALIVA, HANSENÍASE, ANTÍGENOS
ABNT
BONFITTO, Nazario Leonardo Barroso et al. Determination of the salivary-phenolic Glycolipid-1 antibody in leprosy patients as a tool to monitoring multidrugtherapy. American Journal of Infectious Diseases, v. 5, n. 4, p. 321-326, 2009Tradução . . Acesso em: 05 set. 2024.APA
Bonfitto, N. L. B., Motta, A. C. F., Furini, R. B., Komesu, M. C., Nascimento, M. M. P. do, Figueiredo, J. F. de C., & Foss, N. T. (2009). Determination of the salivary-phenolic Glycolipid-1 antibody in leprosy patients as a tool to monitoring multidrugtherapy. American Journal of Infectious Diseases, 5( 4), 321-326.NLM
Bonfitto NLB, Motta ACF, Furini RB, Komesu MC, Nascimento MMP do, Figueiredo JF de C, Foss NT. Determination of the salivary-phenolic Glycolipid-1 antibody in leprosy patients as a tool to monitoring multidrugtherapy. American Journal of Infectious Diseases. 2009 ; 5( 4): 321-326.[citado 2024 set. 05 ]Vancouver
Bonfitto NLB, Motta ACF, Furini RB, Komesu MC, Nascimento MMP do, Figueiredo JF de C, Foss NT. Determination of the salivary-phenolic Glycolipid-1 antibody in leprosy patients as a tool to monitoring multidrugtherapy. American Journal of Infectious Diseases. 2009 ; 5( 4): 321-326.[citado 2024 set. 05 ]